Press Releases

Press Releases

Takeda Pharmaceutical Company Limited and NEUTEC ILAC SANAYI VE TICARET A.S ("Neutec”) today announced that Takeda’s wholly-owned subsidiary, Takeda GmbH, and Neutec have signed an agreement to obtain a select portfolio from Neutec, composed of 13 products in the gastroenterology, respiratory, metabolic and musculoskeletal therapeutic areas, through the acquisition of…

Press Releases

Glenmark Generics Inc., USA, the subsidiary of Glenmark Generics Limited today announced the U.S. market approval and introduction of Ashlyna™(levonorgestrel/ethinyl estradiol and ethinyl estradiol) Extended-Cycle Oral Contraceptive Tablets, the generic equivalent of Seasonique® by Teva Women’s Health. Seasonique® is indicated for use by women to prevent pregnancy. According to IMS…

Press Releases

N30 Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the development of product candidates for cystic fibrosis (CF), announced today that the Company has changed its name to Nivalis Therapeutics, Inc.  The Company's lead product candidate, N91115, is a novel inhibitor of S-nitrosoglutathione reductase (GSNOR). The new corporate name, Nivalis…

Press Releases

Building next generation competency development, succession planning and talent management programs: Attract, develop, retain and engage high potentials & talented people during tough times The public sector faces more than just politics when it comes to succession planning; it also faces budget cuts and hiring freezes. The outlook for human…

Wednesday, Feb 25, 2015
Press Releases

In this 4 days masterclass, we will outline the 3 keys that are crucial to your bidding success - Position Yourself To Win, End-To-End Control & Pricing To Win. On day 3, we will introduce the 3Ps Process and explore how to stop selling to your clients so they want…

Press Releases

Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the discovery and development of novel drug candidates based on proprietary macrocyclic chemistry and Fundación MEDINA (Fundación Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía), a non-profit research organization established through a private-public partnership between the Government of Andalucía…

Press Releases

Baxter International Inc. announced that Baxalta Incorporated, the biopharmaceutical company that is expected to separate from Baxter in mid-2015, will be headquartered in Northern Illinois at 1200 Lakeside Drive, Bannockburn, Ill. The long-term lease agreement for the approximately 260,000 square foot facility extends for more than a decade. "Selecting Baxalta's…

Press Releases

Rigel Pharmaceuticals, Inc. and Bristol-Myers Squibb Company today announced that they have entered into a collaboration agreement for the discovery, development and commercialization of cancer immunotherapies based on Rigel's extensive portfolio of small molecule TGF beta receptor kinase inhibitors. TGF beta can promote tumor growth, broadly suppress the immune system…

Press Releases

Aequus Pharmaceuticals Inc. is pleased to announce that it has received a receipt (the "Receipt") for a final prospectus filed with securities regulators in British Columbia, Alberta, Manitoba and Ontario (the "Jurisdictions") on February 19, 2015 (the "Prospectus"). The receipt makes Aequus a reporting issuer in the Jurisdictions with all…

Press Releases

Shire plc announced its support of Rare Disease Day 2015 by calling for improvements in the journey to diagnosis for those living with a rare disease. Under a new educational initiative, "Diagnosis Doesn't Have to be Rare", Shire is launching a series of educational materials for Rare Disease Day, highlighting…